Dysinnervated but viable myocardium in ischemic heart disease

Journal of Nuclear Cardiology

Volumn 17, Issue 6, 2010, Pages 1107-1115

  Fallavollita, James A ^a,b   Canty Jr , John M ^a,b,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b University at Buffalo The State University of New York   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 3 HYDROXYEPHEDRINE; FLUORODEOXYGLUCOSE F 18; TETROFOSMIN TC 99M;

ARRHYTHMOGENESIS; ARTICLE; AUTONOMIC DENERVATION; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MOLECULAR IMAGING; MYOCARDIAL HIBERNATION; NONHUMAN; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STUNNED HEART MUSCLE; SYMPATHETIC NERVE DYSFUNCTION;

ACUTE DISEASE; ANIMALS; HEART; HUMANS; ISCHEMIA; LIGANDS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NERVOUS SYSTEM DISEASES; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RISK; SWINE; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM;

EID: 78651336298     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-010-9292-5     Document Type: Article

References (60)

1. Link JM, Caldwell JH. Diagnostic and prognostic imaging of the cardiac sympathetic nervous system. Nat Clin Pract Cardiovasc Med 2008;5:S79-86.
2. Bengel FM, Schwaiger M. Assessment of cardiac sympathetic neuronal function using PET imaging. J Nucl Cardiol 2004;11: 603-16.
3. Barber MJ, Mueller TM, Henry DP, Felten SY, Zipes DP. Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation 1983;67:787-96.
4. Ciuffo AA, Ouyang P, Becker LC, Levin L, Weisfeldt ML. Reduction of sympathetic inotropic response after ischemia in dogs. Contributor to stunned myocardium. J Clin Invest 1985;75: 1504-9.
5. Dae MW, Herre JM, O'Connell JW, Botvinick EH, Newman D, Munoz L. Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural myocardial infarction. J Am Coll Cardiol 1991;17:1416-23.
6. Inoue H, Zipes DP. Results of sympathetic denervation in the canine heart: Supersensitivity that may be arrhythmogenic. Circulation 1987;75:877-87.
7. Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res 2004;95:754-63.
8. Rubart M, Zipes DP. Mechanisms of sudden cardiac death. J Clin Invest 2005;115:2305-15.
9. Cao JM, Chen LS, KenKnight BH, Ohara T, Lee MH, Tsai J, et al. Nerve sprouting and sudden cardiac death. Circ Res 2000;86: 816-21.
10. Allman KC, Wieland DM, Muzik O, DeGrado TR, Wolfe ER Jr, Schwaiger M. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol 1993;22:368-75.
11. Joho S, Asanoi H, Takagawa J, Kameyama T, Hirai T, Nozawa T, et al. Cardiac sympathetic denervation modulates the sympathoexcitatory response to acute myocardial ischemia. J Am Coll Cardiol 2002;39:436-42.
12. Gutterman DD, Morgan DA, Miller FJ. Effect of brief myocardial ischemia on sympathetic coronary vasoconstriction. Circ Res 1992;71:960-9.
13. Pettersen MD, Abe T, Morgan DA, Gutterman DD. Role of adenosine in postischemic dysfunction of coronary innervation. Circ Res 1995;76:95-101.
14. Abe H, Morgan DA, Gutterman DD. Role of adenosine receptor subtypes in neural stunning of sympathetic coronary innervation. Am J Physiol Heart Circ Physiol 1997;272:H25-34.
15. Dae MW, O'Connell JW, Botvinick EH, Chin MC. Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content. Cardiovasc Res 1995;30:270-80.
16. Fallavollita JA, Canty JM Jr. Differential 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion: Evidence for chronic stunning in pigs. Circulation 1999; 99:2798-805.
17. Luisi AJ Jr, Suzuki G, de Kemp R, Haka MS, Toorongian SA, Canty JM Jr, et al. Regional 11C-hydroxyephedrine retention in hibernating myocardium: Chronic inhomogeneity of sympathetic innervation in the absence of infarction. J Nucl Med 2005;46: 1368-74.
18. Canty JM, Fallavollita JA. Hibernating myocardium. J Nucl Cardiol 2005;12:104-19.
19. 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium: Evidence for transmural variations in chronic hibernating myocardium. Circulation 1997;95:1900-9.
20. Ovchinnikov V, Suzuki G, Canty JM Jr, Fallavollita JA. Blunted functional responses to pre- and postjunctional sympathetic stimulation in hibernating myocardium. Am J Physiol Heart Circ Physiol 2005;289:H1719-28.
21. Ovchinnikov V, Canty JM, Jr, Fallavollita JA. Hibernating myocardium leads to an upregulation in nerve growth factor and partial subendocardial sympathetic denervation. J Am Coll Cardiol. 2007; 49:34A.
22. Fallavollita JA, Logue M, Canty JM Jr. Stability of hibernating myocardium in pigs with a chronic left anterior descending coronary artery stenosis: Absence of progressive fibrosis in the setting of stable reductions in flow, function and coronary flow reserve. J Am Coll Cardiol 2001;37:1989-95.
23. Lynch P, Lee T-C, Fallavollita J, Canty JJM, Suzuki G. Intra-coronary administration of AdvFGF-5 (Fibroblast Growth Factor- 5) ameliorates left ventricular dysfunction and prevents myocyte loss in swine with developing collaterals and ischemic cardiomyopathy. Circulation 2007;116:I-71-6.
24. Canty JM Jr, Suzuki G, Banas MD, Verheyen F, Borgers M, Fallavollita JA. Hibernating myocardium: Chronically adapted to ischemia but vulnerable to sudden death. Circ Res 2004;94: 1142-9.
25. Banas MD, Page B, Young RF, Fallavollita JA, Canty JM Jr. Residual dysfunction after revascularization of hibernating myocardium is independent of fibrosis and secondary to myocyte loss and persistent regional reduction in mitochondrial oxidative enzymes. Circulation 2006;114:II-66.
26. Banas MD, Young H, Fallavollita JA, Canty JM Jr. Persistent reductions in flow and function after revascularization of swine with hibernating myocardium. J Am Coll Cardiol 2006;47:179A.
27. Suzuki G, Iyer V, Cimato T, Canty JM Jr. Pravastatin improves function in hibernating myocardium by mobilizing CD133+ and cKit+ hematopoietic progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle. Circ Res 2009;104:255-64.
28. Fallavollita JA, Banas MD, Suzuki G, de Kemp RA, Sajjad M, Canty JM Jr. 11C-meta-hydroxyephedrine defects persist despite functional improvement in hibernating myocardium. J Nucl Cardiol 2010;17:85-96.
29. Patel AD, Iskandrian AE. MIBG imaging. J Nucl Cardiol 2002;9:75-94.
30. Simula S, Lakka T, Kuikka J, Laitinen T, Remes J, Kettunen R, et al. Cardiac adrenergic innervation within the first 3 months after acute myocardial infarction. Clin Physiol 2000;20:366-73.
31. Matsunari I, Schricke U, Bengel FM, Haase HU, Barthel P, Schmidt G, et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation 2000;101:2579-85.
32. Guertner C, Klepzig H Jr, Maul FD, Hartmann A, Lelbach S, Hellmann A, et al. Noradrenaline depletion in patients with coronary artery disease before and after percutaneous transluminal coronary angioplasty with iodine-123 metaiodobenzylguanidine and single-photon emission tomography. Eur J Nucl Med 1993;20:776-82.
33. Hartikainen J, Mustonen J, Kuikka J, Vanninen E, Kettunen R. Cardiac sympathetic denervation in patients with coronary artery disease without previous myocardial infarction. Am J Cardiol 1997;80:273-7.
34. Bulow HP, Stahl F, Lauer B, Nekolla SG, Schuler G, Schwaiger M, et al. Alterations of myocardial presynaptic sympathetic innervation in patients with multi-vessel coronary artery disease but without history of myocardial infarction. Nucl Med Commun 2003;24:233-9.
35. Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: A systematic review. Eur Heart J 2008;29:1147-59.
36. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lobez VA, et al. Myocardial iodine-123 Meta-Iodobenzylguanidine imaging and cardiac events in heart failure. J Am Coll Cardiol 2010;55:2212-21.
37. Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverterdefibrillator patients. J Am Coll Cardiol 2010;55:2769-77.
38. Sasano T, Abraham MR, Chang KC, Ashikaga H, Mills KJ, Holt DP, et al. Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 2008;51:2266-75.
39. Kramer CM, Nicol PD, Rogers WJ, Suzuki MM, Shaffer A, Theobald TM, et al. Reduced sympathetic innervation underlies adjacent noninfarcted region dysfunction during left ventricular remodeling. J Am Coll Cardiol 1997;30:1079-85.
40. Zhou S, Chen LS, Miyauchi Y, Miyauchi M, Kar S, Kangavari S, et al. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res 2004;95:76-83.
41. Liu YB, Wu CC, Lu LS, Su MJ, Lin CW, Lin SF, et al. Sympathetic nerve sprouting, electrical remodeling, and increased vulnerability to ventricular fibrillation in hypercholesterolemic rabbits. Circ Res 2003;92:1145-52.
42. Cao JM, Fishbein MC, Han JB, Lai WW, Lai AC, Wu TJ, et al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 2000;101:1960-9.
43. Luisi AJ Jr, Fallavollita JA, Suzuki G, Canty JM Jr. Spatial inhomogeneity of sympathetic nerve function in hibernating myocardium. Circulation 2002;106:779-81.
44. Merlet P, Pouillart F, Dubois-Rande JL, Delahaye N, Fumey R, Castaigne A, et al. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart. J Nucl Med 1999;40:224-31.
45. de Milliano PA, van Eck-Smit BL, van Zwieten PA, de Groot AC, Tijssen JG, Lie KI. Relationship between cardiac metaiodobenzylguanidine uptake and hemodynamic, functional and neurohormonal parameters in patients with heart failure. Eur J Heart Fail 2001;3:693-7.
46. de Milliano PA, Tijssen JG, van Eck-Smit BL, Lie KI. Cardiac 123 I-MIBG imaging and clinical variables in risk stratification in patients with heart failure treated with beta blockers. Nucl Med Commun 2002;23:513-9.
47. Bengel FM, Ueberfuhr P, Ziegler SI, Nekolla S, Reichart B, Schwaiger M. Serial assessment of sympathetic reinnervation after orthotopic heart transplantation. A longitudinal study using PET and C-11 hydroxyephedrine. Circulation 1999;99:1866-71.
48. Odaka K, von Scheidt W, Ziegler SI, Ueberfuhr P, Nekolla SG, Reichart B, et al. Reappearance of cardiac presynaptic sympathetic nerve terminals in the transplanted heart: Correlation between PET using 11C-hydroxyephedrine and invasively measured norepinephrine release. J Nucl Med 2001;42:1011-6.
49. Hartikainen J, Kuikka J, Mantysaari M, Lansimies E, Pyorala K. Sympathetic reinnervation after acute myocardial infarction. Am J Cardiol 1996;77:5-9.
50. Fallen EL, Coates G, Nahmias C, Chirakal R, Beanlands R, Wahl L, et al. Recovery rates of regional sympathetic reinnervation and myocardial blood flow after acute myocardial infarction. Am Heart J 1999;137:863-9.
51. Fallavollita JA, Luisi J,AJ, Michalek SM, Valverde AM, de Kemp RA, Haka MS, et al. Prediction of ARrhythmic events with positron emission tomography: PAREPET study design and methods. Contemp Clin Trials 2006;27:374-88.
52. Fallavollita JA, Luisi AJ Jr, Yun E, Dekemp RA, Canty JM Jr. An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy. J Nucl Cardiol 2010;17:637-45.
53. John AS, Mongillo M, Depre C, Khan MT, Rimoldi OE, Pepper JR, et al. Pre- and post-synaptic sympathetic function in human hibernating myocardium. Eur J Nucl Med Mol Imaging 2007;34:1973-80.
54. Caldwell JH, Link JM, Levy WC, Poole JE, Stratton JR. Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure. J Nucl Med 2008;49:234-41.
55. Munch G, Nguyen NT, Nekolla S, Ziegler S, Muzik O, Chakr-aborty P, et al. Evaluation of sympathetic nerve terminals with [11C]epinephrine and [11C]hydroxyephedrine and positron emission tomography. Circulation 2000;101:516-23.
56. Bucerius J, Joe AY, Schmaljohann J, Gundisch D, Minnerop M, Biersack HJ, et al. Feasibility of 2-deoxy-2-[18F]fluoro-D-glucose- A85380-PET for imaging of human cardiac nicotinic acetylcholine receptors in vivo. Clin Res Cardiol 2006;95: 105-9.
57. Mazzadi AN, Pineau J, Costes N, Le Bars D, Bonnefoi F, Croisille P, et al. Muscarinic receptor upregulation in patients with myocardial infarction: a new paradigm. Circ Cardiovasc Imaging 2009;2:365-72.
58. Caldwell JH, Kroll K, Li Z, Seymour K, Link JM, Krohn KA. Quantitation of presynaptic cardiac sympathetic function with carbon-11-meta-hydroxyephedrine. J Nucl Med 1998;39:1327-34.
59. Mongillo M, John AS, Leccisotti L, Pennell DJ, Camici PG. Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart. Eur J Nucl Med Mol Imaging 2007;34:1172-7.
60. Link JM, Stratton JR, Levy W, Poole JE, Shoner SC, Stuetzle W, et al. PET measures of pre- and post-synaptic cardiac beta adrenergic function. Nucl Med Biol 2003;30:795-803.